The monitoring of progress in apoptosis of liver cells in bile duct-ligated rats

Turkish Journal of Gastroenterology

Volumn 20, Issue 4, 2009, Pages 247-256

  Dirlik, Musa ^a   Canbaz, Hakan ^a   Düşmez Apa, Duygu ^a   Çaǧlikülekçi, Mehmet ^a   Yaylak, Faik ^a   Balli, Ebru ^a   Tamer, Lülüfer ^a   Kanik, Arzu ^a   Aydin, Süha ^a  

^a MERSIN UNIVERSITY   (Turkey)

Author keywords

Apoptosis; Cholestasis; Inducible nitric oxide synthase; Lipid peroxidation; Reduced glutathione; Ultrastructure

Indexed keywords

BILIRUBIN; GLUTATHIONE; INDUCIBLE NITRIC OXIDE SYNTHASE; MALONALDEHYDE;

APOPTOSIS; ARTICLE; BILE DUCT LIGATION; BILIRUBIN BLOOD LEVEL; CONTROLLED STUDY; ELECTRON MICROSCOPY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LIPID PEROXIDATION; LIVER CELL; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT;

ACUTE DISEASE; ANIMALS; APOPTOSIS; BILE DUCTS; BILIRUBIN; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; GLUTATHIONE; HEPATOCYTES; IMMUNOHISTOCHEMISTRY; JAUNDICE, OBSTRUCTIVE; LIGATION; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; MICROSCOPY, ELECTRON; NITRIC OXIDE SYNTHASE TYPE II; RATS; RATS, WISTAR;

EID: 74949121366     PISSN: 13004948     EISSN: None     Source Type: Journal    
DOI: 10.4318/tjg.2009.0021     Document Type: Article

References (31)

1. Greig JD, Krukowski ZH, Matheson NA. Surgical morbidity and mortality in one hundred and twenty-nine patients with obstructive jaundice. Br J Surg 1988; 75: 216-9.
2. Miyoshi H, Rust C, Roberts PJ, et al. Hepatocyte apoptosis after bile duct ligation in the mouse involves Fas. Gastroenterology 1999; 117: 669-77.
3. Miyoshi H, Rust C, Guicciardi ME, Gores GJ. NF-kappaB is activated in cholestasis and functions to reduce liver injury. Am J Pathol 2001; 158: 967-75.
4. Lechner AJ, Velasquez A, Knudsen KR, et al. Cholestatic liver injury increases circulating TNF-alpha and IL-6 and mortality after Escherichia coli endotoxemia. Am J Respir Crit Care Med 1998; 157: 1550-8.
5. Moazzam FN, Brems JJ, Yong SL, et al. Endotoxin potentiates hepatocyte apoptosis in cholestasis. J Am Coll Surg 2002; 194: 731-9.
6. Liu TZ, Lee KT, Chern CL, et al. Free radical-triggered hepatic injury of experimental obstructive jaundice of rats involves overproduction of proinflammatory cytokines and enhanced activation of nuclear factor kappaB. Ann Clin Lab Sci 2001; 31: 383-90.
7. Ito Y, Machen NW, Urbaschek R, McCuskey RS. Biliary obstruction exacerbates the hepatic microvascular inflammatory response to endotoxin. Shock 2000; 14: 599-604.
8. Houdijk AP, van Lambalgen AA, Thijs LG, Van Leeuwen PA. Gut endotoxin restriction improves postoperative hemodynamics in the bile duct-ligated rat. Shock 1998; 9: 282-8.
9. Arriero MM, Lopez-Farre A, Fryeiro O, et al. Expression of inducible nitric oxide synthase in the liver of bile duct-ligated Wistar rats with modulation by lymphomononuclear cells. Surgery 2001; 129: 255-66.
10. Holt S, Marley R, Fernando B, et al. Acute cholestasis-induced renal failure: effects of antioxidants and ligands for the thromboxane A2 receptor. Kidney Int 1999; 55: 271-7.
11. Xie QW, Kashiwabara Y, Nathan C. Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. J Biol Chem 1994; 269: 4705-8.
12. Hatano E, Bennett BL, Manning AM, et al. NF-kappaB stimulates inducible nitric oxide synthase to protect mouse hepatocytes from TNF-alpha- and Fas-mediated apoptosis. Gastroenterology 2001; 120: 1251-62.
13. Lee E. The effect of obstructive jaundice on the migration of reticulo-endothelial cells and fibroblasts into early experimental granulomata. Br J Surg 1972; 59: 875-7.
14. Yagi K. Lipid peroxides and related radicals in clinical medicine. In: Armstrong D, ed. Free radicals in diagnostic medicine. New York: Plenum Press, 1994; 1-15.
15. Lowry OH, Roscbrough NJ, Farr AI, Randat RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1954; 193: 265-75.
16. Lauterburg BH, Dickson ER, Pineda AA, Taswell HF. Depletion of bile acids and bilirubin in dogs with biliary obstruction by plasma perfusion of USP-charcoal-coated glass beads. Int J Artif Organs 1980; 3: 281-5.
17. Hofmann AF. Cholestatic liver disease: pathophysiology and therapeutic options. Liver 2002; 22: 14-9.
18. Bomzon A, Holt S, Moore K. Bile acids, oxidative stress, and renal function in biliary obstruction. Semin Nephrol 1997; 17: 549-62.
19. Schoemaker MH, Ros JE, Homan M, et al. Cytokine regulation of pro- and anti-apoptotic genes in rat hepatocytes: NF-kappaB-regulated inhibitor of apoptosis protein 2 (cI-AP2) prevents apoptosis. J Hepatol 2002; 36: 742-50.
20. LaCasse EC, Baird S, Korneluk RG, MacKenzie AE. The inhibitors of apoptosis (IAPs) and their emerging role in cancer. Oncogene 1998; 17: 3247-59.
21. Wang K, Brems JJ, Gamelli RL, Ding J. Reversibility of caspase activation and its role during glycochenodeoxycholate-induced hepatocyte apoptosis. J Biol Chem 2005; 280: 23490-5.
22. Xiong S, She H, Takeuchi H, et al. Signaling role of intracellular iron in NF-kappaB activation. J Biol Chem 2003; 278: 17646-54.
23. Schoemaker MH, Gommans WM, Conde de la Rosa L, et al. Resistance of rat hepatocytes against bile acid-induced apoptosis in cholestatic liver injury is due to nuclear factor-kappa B activation. J Hepatol 2003; 39: 153-61.
24. Kim YM, de Vera ME, Watkins SC, Billiar TR. Nitric oxide protects cultured rat hepatocytes from tumor necrosis factor-alpha-induced apoptosis by inducing heat shock protein 70 expression. J Biol Chem 1997; 272: 1402-11.
25. Kim YM, Son K, Hong SJ, et al. Inhibition of protein synthesis by nitric oxide correlates with cytostatic activity: nitric oxide induces phosphorylation of initiation factor eIF-2 alpha. Mol Med 1998; 4: 179-90.
26. Tzeng E, Billiar TR, Williams DL, et al. Adenovirus-mediated inducible nitric oxide synthase gene transfer inhibits hepatocyte apoptosis. Surgery 1998; 124: 278-83.
27. Geller DA, Lowenstein CJ, Shapiro RA, et al. Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. Proc Natl Acad Sci U S A 1993; 90: 3491-5.
28. McNaughton L, Puttagunta L, Martinez-Cuesta MA, et al. Distribution of nitric oxide synthase in normal and cirrhotic human liver. Proc Natl Acad Sci U S A 2002; 99: 17161-6.
29. de Belder AJ, Radomski MW. Nitric oxide in the clinical arena. J Hypertens 1994; 12: 617-24.
30. Li J, Billiar TR. Nitric oxide. IV. Determinants of nitric oxide protection and toxicity in liver. Am J Physiol 1999; 276(5 Pt 1): G1069-G1073.
31. Baron V, Hernandez J, Noyola M, et al. Nitric oxide and inducible nitric oxide synthase expression are down regulated in acute cholestasis in the rat accompanied by liver ischemia. Comp Biochem Physiol C Toxicol Pharmacol 2000; 127: 243-9.